| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99091 |
|
827 |
729 |
$107K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,304 |
1,039 |
$49K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
825 |
702 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
256 |
207 |
$11K |
| 99000 |
|
916 |
795 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
471 |
382 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
77 |
70 |
$4K |
| 99402 |
|
472 |
364 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
47 |
45 |
$4K |
| 95816 |
|
21 |
19 |
$2K |
| 99403 |
|
165 |
137 |
$2K |
| 99401 |
|
405 |
353 |
$2K |
| 95957 |
|
21 |
19 |
$1K |
| 99441 |
|
222 |
183 |
$994.52 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
41 |
38 |
$822.84 |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$664.26 |
| H0049 |
Alcohol and/or drug screening |
123 |
108 |
$583.71 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
119 |
109 |
$563.65 |
| 95930 |
|
21 |
19 |
$552.01 |
| 80305 |
|
75 |
70 |
$550.87 |
| 96112 |
|
12 |
12 |
$479.94 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
103 |
94 |
$472.40 |
| 96127 |
|
742 |
660 |
$469.07 |
| 99490 |
Ccm add 20min |
38 |
34 |
$450.96 |
| 92653 |
|
21 |
19 |
$389.00 |
| 80053 |
Comprehensive metabolic panel |
65 |
57 |
$348.40 |
| 90832 |
Psychotherapy, 30 minutes with patient |
14 |
14 |
$275.07 |
| 82607 |
|
60 |
55 |
$250.91 |
| 92650 |
|
21 |
19 |
$215.82 |
| 80061 |
Lipid panel |
96 |
88 |
$209.86 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
47 |
44 |
$206.80 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
47 |
44 |
$206.80 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
47 |
44 |
$195.20 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
31 |
28 |
$190.90 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
76 |
67 |
$169.65 |
| 93040 |
|
21 |
19 |
$127.40 |
| 84443 |
Thyroid stimulating hormone (TSH) |
45 |
40 |
$119.30 |
| 81005 |
|
90 |
81 |
$94.44 |
| G9393 |
Patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five |
62 |
60 |
$87.50 |
| 81025 |
|
14 |
14 |
$81.55 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
88 |
68 |
$76.27 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
13 |
12 |
$69.90 |
| 3085F |
|
87 |
75 |
$61.25 |
| 36415 |
Collection of venous blood by venipuncture |
520 |
469 |
$52.50 |
| 98960 |
|
37 |
32 |
$52.50 |
| G9395 |
Patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five |
55 |
50 |
$21.00 |
| 99458 |
|
44 |
44 |
$0.00 |
| 99457 |
|
47 |
45 |
$0.00 |
| 96156 |
|
19 |
17 |
$0.00 |
| 96132 |
|
22 |
20 |
$0.00 |
| 96139 |
|
21 |
19 |
$0.00 |
| 96138 |
|
21 |
19 |
$0.00 |